Page last updated: 2024-10-27

fluorouracil and Acrospiroma

fluorouracil has been researched along with Acrospiroma in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Acrospiroma: A rare cutaneous tumor of apocrine or eccrine SWEAT GLAND origin. It is most commonly found on the extremities and is usually benign. It appears as a solitary nodule or cyst and may be solid or produce a watery discharge. It is related to POROMA except in acrospiroma it does not involve the epidermis. There is no indication that heredity or external agents cause these tumors.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lerner, A1
Beckford, A1
Ugent, S1
Goldberg, L1
Jalisi, S1
Demierre, MF1
de Bree, E1
Volalakis, E1
Tsetis, D1
Varthalitis, Y1
Panagiotidis, J1
Romanos, J1
Tsiftsis, DD1

Other Studies

2 other studies available for fluorouracil and Acrospiroma

ArticleYear
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.
    Archives of dermatology, 2011, Volume: 147, Issue:8

    Topics: Acrospiroma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Human

2011
Treatment of advanced malignant eccrine poroma with locoregional chemotherapy.
    The British journal of dermatology, 2005, Volume: 152, Issue:5

    Topics: Acrospiroma; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; F

2005